Mesenchymal stem cells for the treatment of severe COVID-19

Abstract

Current regenerative medicine is based on the use of mesenchymal stem cells through which regenerative and immunomodulatory properties have been seen. In this last respect, it has been hypothesized that the use of mesenchymal stem cells in severe acute inflammatory conditions such as those seen in cases of Sars Cov2 infection may benefit from the use of this therapy due to the anti-inflammatory, immunomodulatory, regenerative properties coupled with These cells do not express the ACE2 receptor, which gives them resistance to the virus.